STOK · CIK 0001623526 · operating
Stoke Therapeutics, Inc. (STOK) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $2.1 billion, Stoke Therapeutics, Inc. is a mid-cap company. The stock currently trades at $36.69, up 0.77% today, with a 52-week range of $5.35–$39.81. The company trades at a trailing P/E of 54.0x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.65 | $-1.65 | +30.7% | |
| 2023 | $-2.38 | $-2.38 | +8.5% | |
| 2022 | $-2.60 | $-2.60 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-18 | 0000950170-25-041170 | SEC ↗ |
| 2023-12-31 | 2024-03-25 | 0000950170-24-035912 | SEC ↗ |
| 2022-12-31 | 2023-03-06 | 0001564590-23-003175 | SEC ↗ |
| 2021-12-31 | 2022-03-10 | 0001564590-22-009634 | SEC ↗ |
| 2020-12-31 | 2021-03-09 | 0001564590-21-011760 | SEC ↗ |
| 2019-12-31 | 2020-03-23 | 0001564590-20-012202 | SEC ↗ |